Skip to content
AnalystLens

PROCTER & GAMBLE Co 8-K Report, Regulation FD Disclosure (Oct 22, 2026)

Reports
Regulation FD·Exhibits & Filings
Filing Date
Filed October 22, 2026
Period End
October 22, 2026
Security
PG
In the record · 2016–202610-K1210-Q328-K228

PG filed 12 annual reports (10-K), 32 quarterly reports (10-Q) and 228 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Jan ’22Jan ’22
  2. Leadership change8-K · Dec ’25Dec ’25

Summary

Summary of the 8-K filed October 22, 2026. Cited figures are marked; the original filing is the authoritative source.

The Procter & Gamble Company (PG) has released its first-quarter fiscal year 2027 results, showcasing resilience and continued growth in a challenging macro environment.

The company reported a solid 4.0%a organic sales growth, driven by a balanced contribution from volume (+2.4%), pricing (+0.4%), and favorable product mix (+1.1%). Notably, all ten product categories and all six global regions achieved organic sales growth, with 29 of the top 50 category/country combinations holding or increasing their value share. Despite facing increasing cost headwinds and market volatility, P&G maintained its strategic focus on integrated growth, superiority, and productivity.

Financially, core earnings per share (EPS) were $2.00b, a 1% increase year-over-year, or flat on a currency-neutral basis. Free cash flow productivity remained strong at 93%. Looking ahead, P&G has reiterated its FY2027 guidance for organic sales growth of 1% to 3% and net sales growth of 2% to 4%.

However, the company anticipates increased cost headwinds in the coming quarters, which will impact margins. Management remains committed to investing in brands, productivity, and returning capital to shareholders through dividends and share repurchases.

Key Highlights

  1. Reported Q1 FY2027 organic sales growth of 4.0%, with all 10 categories and 6 regions contributing positively.
  2. Achieved 2.4% organic volume growth and 1.1% favorable product mix, indicating strong consumer demand and effective product strategy.
  3. Core EPS reached $2.00, a 1% increase year-over-year, with currency-neutral Core EPS remaining flat.
  4. Strong Free Cash Flow productivity of 93% was maintained, underscoring efficient cash generation.
  5. Reiterated full-year FY2027 guidance for organic sales growth (1-3%) and net sales growth (2-4%).
  6. Acknowledged increasing cost headwinds (commodity, transportation, energy) expected in upcoming quarters.
  7. 29 of the top 50 category/country combinations held or grew value share, demonstrating competitive strength in key markets.

Frequently Asked Questions

  1. What was the primary driver of Procter & Gamble's organic sales growth in Q1 FY2027?

    Procter & Gamble's organic sales growth of 4.0% in Q1 FY2027 was driven by a combination of organic volume growth (+2.4%), pricing (+0.4%), and a favorable product mix (+1.1%). This indicates broad-based strength across the portfolio and regions.

  2. What is the company's outlook on costs and margins for the remainder of FY2027?

    P&G anticipates cost headwinds to increase in the next few quarters, particularly from commodity, transportation, and energy costs. While the company reiterated its sales guidance, these increased costs are expected to put pressure on margins.

  3. How did Procter & Gamble perform in terms of market share in its key categories/countries?

    In Q1 FY2027, 29 of P&G's top 50 category/country combinations held or grew their value share. This highlights the company's ability to maintain or improve its competitive position in significant markets despite a challenging environment.

  4. What is the company's guidance for earnings per share (EPS) for FY2027?

    Procter & Gamble maintained its guidance for FY2027 Core EPS growth of 0% to 3% and All-in EPS growth of 1% to 5%. This guidance reflects the expected sales performance and the anticipated cost pressures and other factors impacting profitability.